The effect of resveratrol on blood lipid profile: a dose-response Meta-analysis of randomized controlled trials
Research spanning 2-3 years of intermittent cycling shows no significant long-term complications in healthy adults
Potential considerations include: Theoretical concern about promoting angiogenesis in existing tumors (not demonstrated but mechanistically plausible) Possible interactions with dopaminergic medications Limited human safety data due to absence of completed clinical trials GHK-Cu Side Effects# GHK-Cu has an established safety profile, particularly for topical use: Topical formulations are generally well-tolerated with low irritation potential Allergic reactions are rare but possible, particularly in individuals with copper sensitivity Injection site reactions (redness, swelling) can occur with subcutaneous administration No significant systemic side effects reported at standard research doses The extensive commercial use of GHK-Cu in cosmetic products provides a broader real-world safety dataset compared to BPC-157
Pregnancy is contraindicated
"Enhancement of pulsatile growth hormone secretion by continuous infusion of a growth hormone-releasing peptide mimetic, L-692,429, in older adults." Journal of Clinical Endocrinology & Metabolism 81.8 (1996): 2874-2880
If a clinic promises guaranteed synergy, be skeptical
